17-15437922-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001204477.2(CDRT4):c.310G>A(p.Ala104Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,614,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001204477.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDRT4 | NM_001204477.2 | c.310G>A | p.Ala104Thr | missense_variant | 4/4 | ENST00000619038.5 | NP_001191406.1 | |
TVP23C-CDRT4 | NM_001204478.2 | c.*324G>A | 3_prime_UTR_variant | 7/7 | NP_001191407.1 | |||
TVP23C-CDRT4 | NR_037924.2 | n.709G>A | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDRT4 | ENST00000619038.5 | c.310G>A | p.Ala104Thr | missense_variant | 4/4 | 1 | NM_001204477.2 | ENSP00000482523.1 | ||
TVP23C-CDRT4 | ENST00000522212 | c.*324G>A | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000429865.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251440Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135880
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727246
GnomAD4 genome AF: 0.000112 AC: 17AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at